Additionally, the amplification percentages of SALL4 (27%) and FGF2 (10%) were determined when the seven-gene signature was analyzed for prostate cancer type (Fig. 3d, lower panel), indicating that co-expression genes of OCT4 partially regulates cancer development. This evidence concerns the gene FGF2 and prostate carcinoma.